Arrakis Therapeutics

Arrakis Therapeutics

Arrakis Therapeutics

Discovering a new world of therapeutics
Raised
$38M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$38,000,000
Venture capital (Series A) - 2017
Canaan Partners Celgene Osage University Partners +3
Team Size
1–10
Employees
MedCity News

Arrakis, Roche sign $190M RNA-targeting platform technology deal

$38,000,000 Venture capital (Series A)
businesswire

Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Mich...